Cargando…

Ulipristal Acetate Modifies miRNA Expression in Both Superficial and Basal Layers of the Human Endometrium

(1) Background: Ulipristal acetate (UPA) is a selective progesterone receptor modulator (SPRM) widely used for emergency contraception and mid- to long-term leiomyoma treatment. The aim of this study was to identify modifications of miRNA expression in superficial and basal layers of the human endom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kolanska, Kamila, Sbeih, Maria, Canlorbe, Geoffroy, Mekinian, Arsène, Varinot, Justine, Capmas, Perrine, Koskas, Martin, Aractingi, Selim, Daraï, Emile, Chabbert-Buffet, Nathalie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509688/ https://www.ncbi.nlm.nih.gov/pubmed/34640460 http://dx.doi.org/10.3390/jcm10194442

Ejemplares similares

Role of miRNAs in Normal Endometrium and in Endometrial Disorders: Comprehensive Review
por: Kolanska, Kamila, et al.
Publicado: (2021)

Identification of micro-RNA expression profile related to recurrence in women with ESMO low-risk endometrial cancer
por: de Foucher, Tiphaine, et al.
Publicado: (2018)

Sickle cell disease and COVID-19 in pregnant women
por: Kolanska, Kamila, et al.
Publicado: (2022)

Fertility-Sparing Surgery for Ovarian Cancer
por: Canlorbe, Geoffroy, et al.
Publicado: (2021)

Stimulation Duration in Patients with Early Oocyte Maturation Triggering Criteria Does Not Impact IVF-ICSI Outcomes
por: Stout, Sophie, et al.
Publicado: (2022)

Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence
por: Trefoux Bourdet, Alice, et al.
Publicado: (2015)

Mild COVID-19 infection does not alter the ovarian reserve in women treated with ART
por: Kolanska, Kamila, et al.
Publicado: (2021)

Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl(2)-L(1) Expression
por: Esber, Nathalie, et al.
Publicado: (2015)

The Role of Immunohistochemistry Markers in Endometrial Cancer with Mismatch Repair Deficiency: A Systematic Review
por: Favier, Amelia, et al.
Publicado: (2022)

Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium
por: Whitaker, L.H.R., et al.
Publicado: (2017)

Ulipristal Acetate in Adenomyosis
por: Gonçalves-Henriques, Manuel, et al.
Publicado: (2022)

PD-L1 expression with QR1 and E1L3N antibodies according to histological ovarian cancer subtype: A series of 232 cases
por: Eymerit-Morin, Caroline, et al.
Publicado: (2021)

Emergency contraception: potential role of ulipristal acetate
por: Gemzell-Danielsson, Kristina, et al.
Publicado: (2010)

Therapy with Ulipristal Acetate in a Hypertensive Patient
por: Alcalde Dominguez, A., et al.
Publicado: (2018)

Symptom relief of leiomyomatosis peritonealis disseminata with ulipristal acetate
por: Verguts, Jasper, et al.
Publicado: (2013)

Ulipristal acetate as a treatment option for uterine fibroids
por: Piecak, Karolina, et al.
Publicado: (2017)

Medical Therapy for Fibroids: What Next for Ulipristal Acetate?
por: Ekanem, Emmanuel, et al.
Publicado: (2020)

Immunopharmacology of ulipristal as an emergency contraceptive
por: Miech, Ralph P
Publicado: (2011)

Ulipristal acetate, a progesterone receptor modulator for emergency contraception
por: Jadav, Shilpa P., et al.
Publicado: (2012)

Successful Pregnancy after Treatment with Ulipristal Acetate for Uterine Fibroids
por: Monleón, Javier, et al.
Publicado: (2014)

Ulipristal Acetate in Myomectomy Optimization in an Infertile Patient with Giant Myomas
por: de la Fuente, Elena, et al.
Publicado: (2016)

Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis
por: Gatti, Milo, et al.
Publicado: (2020)

Risk–efficacy balance of ulipristal acetate compared to surgical alternatives
por: Middelkoop, Mei‐An, et al.
Publicado: (2021)

Ccl2/Ccr2 signalling recruits a distinct fetal microchimeric population that rescues delayed maternal wound healing
por: Castela, Mathieu, et al.
Publicado: (2017)

Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids
por: Biglia, Nicoletta, et al.
Publicado: (2014)

Expulsion of a uterine myoma in a patient treated with ulipristal acetate
por: Chantraine, Frederic, et al.
Publicado: (2015)

Mechanism of Action of Ulipristal Acetate for Emergency Contraception: A Systematic Review
por: Rosato, Elena, et al.
Publicado: (2016)

Ulipristal acetate induces cell cycle delay and remodeling of extracellular matrix
por: Shin, So-Jin, et al.
Publicado: (2018)

The Use of Ulipristal Acetate (Esmya) Prior to Laparoscopic Myomectomy: Help or Hindrance?
por: Mallick, Rebecca, et al.
Publicado: (2019)

Safety after extended repeated use of ulipristal acetate for uterine fibroids
por: Fauser, Bart C. J. M., et al.
Publicado: (2017)

Economic impact of ulipristal acetate on surgical procedures for uterine fibroids in France
por: Fernandez, Hervé, et al.
Publicado: (2017)

Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids
por: Middelkoop, Mei-An, et al.
Publicado: (2022)

Cyclodextrin and its derivatives as effective excipients for amorphous ulipristal acetate systems
por: Wang, Peng, et al.
Publicado: (2022)

Suspension of ulipristal acetate for uterine fibroids during ongoing EMA’s review of liver injury risk: Unfortunate timing during the Covid-19 pandemic!
por: Rozenberg, Serge, et al.
Publicado: (2020)

Failure of ulipristal acetate treatment as an indication for uterine malignancy: Two case reports
por: Santoro, Angela, et al.
Publicado: (2018)

Ulipristal Acetate Efficacy in a Patient with Symptomatic Fibroid and Concomitant Pulmonary Embolism
por: von Wunster, S., et al.
Publicado: (2020)

Ulipristal acetate before in vitro fertilization: efficacy in infertile women with submucous fibroids
por: Morgante, Giuseppe, et al.
Publicado: (2020)

Ulipristal acetate simultaneously provokes antiproliferative and proinflammatory responses in endometrial cancer cells
por: Kanda, Ranka, et al.
Publicado: (2021)

Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate
por: Kolterud, Åsa, et al.
Publicado: (2022)

Effectiveness of gefitinib in combination with methotrexate in the treatment of ectopic pregnancy
por: Capmas, Perrine, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7uqd0teo132rrjom255dptru79